Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers

Sandra Russo; Joan L. Walker; Jay W. Carlson; Jeanne Carter; Leigh C. Ward; Allan Covens; Edward J. Tanner; Jane M. Armer; Sheila Ridner; Sandi Hayes; Alphonse G. Taghian; Cheryl Brunelle; Micael Lopez-Acevedo; Brittany A. Davidson; Mark V. Schaverien; Sharad A. Ghamande; Michael Bernas; Andrea L. Cheville; Kathleen J. Yost; Kathryn Schmitz; Barbara Coyle; Jeannette Zucker; Danielle Enserro; Stephanie Pugh; Electra D. Paskett; Leslie Ford; Worta McCaskill-Stevens

doi:10.1016/j.ygyno.2020.10.026

Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers

Sandra Russo, Joan L. Walker, Jay W. Carlson, Jeanne Carter, Leigh C. Ward, Allan Covens, Edward J. Tanner, Jane M. Armer, Sheila Ridner, Sandi Hayes, Alphonse G. Taghian, Cheryl Brunelle, Micael Lopez-Acevedo, Brittany A. Davidson, Mark V. Schaverien, Sharad A. Ghamande, Michael Bernas, Andrea L. Cheville, Kathleen J. Yost, Kathryn SchmitzBarbara Coyle, Jeannette Zucker, Danielle Enserro, Stephanie Pugh, Electra D. Paskett, Leslie Ford, Worta McCaskill-Stevens

Research output: Contribution to journal › Review article › peer-review

19 Scopus citations

Abstract

Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.

Original language	English (US)
Pages (from-to)	625-632
Number of pages	8
Journal	Gynecologic Oncology
Volume	160
Issue number	2
DOIs	https://doi.org/10.1016/j.ygyno.2020.10.026
State	Published - Feb 2021

All Science Journal Classification (ASJC) codes

Oncology
Obstetrics and Gynecology

Access to Document

10.1016/j.ygyno.2020.10.026

Cite this

Russo, S., Walker, J. L., Carlson, J. W., Carter, J., Ward, L. C., Covens, A., Tanner, E. J., Armer, J. M., Ridner, S., Hayes, S., Taghian, A. G., Brunelle, C., Lopez-Acevedo, M., Davidson, B. A., Schaverien, M. V., Ghamande, S. A., Bernas, M., Cheville, A. L., Yost, K. J., ... McCaskill-Stevens, W. (2021). Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers. Gynecologic Oncology, 160(2), 625-632. https://doi.org/10.1016/j.ygyno.2020.10.026

@article{414a549600b24ec78e5086b48eb6f2ef,

title = "Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers",

abstract = "Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.",

author = "Sandra Russo and Walker, {Joan L.} and Carlson, {Jay W.} and Jeanne Carter and Ward, {Leigh C.} and Allan Covens and Tanner, {Edward J.} and Armer, {Jane M.} and Sheila Ridner and Sandi Hayes and Taghian, {Alphonse G.} and Cheryl Brunelle and Micael Lopez-Acevedo and Davidson, {Brittany A.} and Schaverien, {Mark V.} and Ghamande, {Sharad A.} and Michael Bernas and Cheville, {Andrea L.} and Yost, {Kathleen J.} and Kathryn Schmitz and Barbara Coyle and Jeannette Zucker and Danielle Enserro and Stephanie Pugh and Paskett, {Electra D.} and Leslie Ford and Worta McCaskill-Stevens",

note = "Publisher Copyright: {\textcopyright} 2020",

year = "2021",

month = feb,

doi = "10.1016/j.ygyno.2020.10.026",

language = "English (US)",

volume = "160",

pages = "625--632",

journal = "Gynecologic Oncology",

issn = "0090-8258",

publisher = "Academic Press Inc.",

number = "2",

}

Russo, S, Walker, JL, Carlson, JW, Carter, J, Ward, LC, Covens, A, Tanner, EJ, Armer, JM, Ridner, S, Hayes, S, Taghian, AG, Brunelle, C, Lopez-Acevedo, M, Davidson, BA, Schaverien, MV, Ghamande, SA, Bernas, M, Cheville, AL, Yost, KJ, Schmitz, K, Coyle, B, Zucker, J, Enserro, D, Pugh, S, Paskett, ED, Ford, L & McCaskill-Stevens, W 2021, 'Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers', Gynecologic Oncology, vol. 160, no. 2, pp. 625-632. https://doi.org/10.1016/j.ygyno.2020.10.026

TY - JOUR

T1 - Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers

AU - Russo, Sandra

AU - Walker, Joan L.

AU - Carlson, Jay W.

AU - Carter, Jeanne

AU - Ward, Leigh C.

AU - Covens, Allan

AU - Tanner, Edward J.

AU - Armer, Jane M.

AU - Ridner, Sheila

AU - Hayes, Sandi

AU - Taghian, Alphonse G.

AU - Brunelle, Cheryl

AU - Lopez-Acevedo, Micael

AU - Davidson, Brittany A.

AU - Schaverien, Mark V.

AU - Ghamande, Sharad A.

AU - Bernas, Michael

AU - Cheville, Andrea L.

AU - Yost, Kathleen J.

AU - Schmitz, Kathryn

AU - Coyle, Barbara

AU - Zucker, Jeannette

AU - Enserro, Danielle

AU - Pugh, Stephanie

AU - Paskett, Electra D.

AU - Ford, Leslie

AU - McCaskill-Stevens, Worta

PY - 2021/2

Y1 - 2021/2

N2 - Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.

AB - Practice changing standardization of lower extremity lymphedema quantitative measurements with integrated patient reported outcomes will likely refine and redefine the optimal risk-reduction strategies to diminish the devastating limb-related dysfunction and morbidity associated with treatment of gynecologic cancers. The National Cancer Institute (NCI), Division of Cancer Prevention brought together a diverse group of cancer treatment, therapy and patient reported outcomes experts to discuss the current state-of-the-science in lymphedema evaluation with the potential goal of incorporating new strategies for optimal evaluation of lymphedema in future developing gynecologic clinical trials.

UR - http://www.scopus.com/inward/record.url?scp=85096382445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85096382445&partnerID=8YFLogxK

U2 - 10.1016/j.ygyno.2020.10.026

DO - 10.1016/j.ygyno.2020.10.026

M3 - Review article

C2 - 33158510

AN - SCOPUS:85096382445

SN - 0090-8258

VL - 160

SP - 625

EP - 632

JO - Gynecologic Oncology

JF - Gynecologic Oncology

IS - 2

ER -

Standardization of lower extremity quantitative lymphedema measurements and associated patient-reported outcomes in gynecologic cancers

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Fingerprint

Cite this